You just read:

Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

News provided by

Janssen Pharmaceuticals, Inc.

May 17, 2012, 01:50 ET